Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK

NCT00216034 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

255

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Tegafur-gimeracil-oteracil potassium (TS-1)
DRUG: Krestin (PSK)

Sponsor

Hokuriku-Kinki Immunochemotherapy Study Group